 |
|
The influence of number of high risk factors on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy and adjuvant chemoradiation
Soyi Lim, Seok-Ho Lee, Kwang Beom Lee, Chan-Yong Park
Obstet Gynecol Sci. 2016;59(3):184-191. Published online 2016 May 13 DOI: https://doi.org/10.5468/ogs.2016.59.3.184
|
|
Citations to this article as recorded by
 Prognostic Factors Analysis of Metastatic Recurrence in Cervical Carcinoma Patients Treated with Definitive Radiotherapy: A Retrospective Study Using Mixture Cure Model
Xiaxian Ou, Jing You, Baosheng Liang, Xiaofan Li, Jiangjie Zhou, Fengyu Wen, Jingyuan Wang, Zhengkun Dong, Yibao Zhang
Cancers.2023; 15(11): 2913. CrossRef Cervical Cancer Stages, Human Papillomavirus Integration, and Malignant Genetic Mutations: Integrative Analysis of Datasets from Four Different Cohorts
Foziya Ahmed Mohammed, Kula Kekeba Tune, Marti Jett, Seid Muhie
Cancers.2023; 15(23): 5595. CrossRef Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study
Jina Li, Gaoming Liu, Jiayou Luo, Shipeng Yan, Ping Ye, Jie Wang, Miyang Luo
Scientific Reports.2022;[Epub] CrossRef Prognostic Factors Associated with 5-Year Overall Survival in Cervical Cancer Patients Treated with Radical Hysterectomy Followed by Adjuvant Concurrent Chemoradiation Therapy at a Tertiary Care Center in Eastern Europe
Mihai Stanca, Mihai Emil Căpîlna
Diagnostics.2021; 11(3): 570. CrossRef Genomic landscape analyses in cervical carcinoma and consequences for treatment
Dominik Diefenbach, Henry Johannes Greten, Thomas Efferth
Current Opinion in Pharmacology.2020; 54: 142. CrossRef
|